iTeos Therapeutics, Inc.·4

Oct 12, 5:09 PM ET

Gall Matthew 4

4 · iTeos Therapeutics, Inc. · Filed Oct 12, 2023

Insider Transaction Report

Form 4
Period: 2023-10-12
Gall Matthew
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2023-10-12$8.37/sh+5,000$41,85019,429 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION